Your browser doesn't support javascript.
loading
Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta-analysis.
Yoshihara, Takeo; Shinzaki, Shinichiro; Amano, Takahiro; Iijima, Hideki; Takehara, Tetsuo; Inoue, Nagamu; Uchino, Motoi; Esaki, Motohiro; Kobayashi, Taku; Saruta, Masayuki; Sugimoto, Ken; Nakamura, Shiro; Hata, Keisuke; Hirai, Fumihito; Hiraoka, Sakiko; Fujii, Toshimitsu; Matsuura, Minoru; Matsuoka, Katsuyoshi; Watanabe, Kenji; Nakase, Hiroshi; Watanabe, Mamoru.
Afiliación
  • Yoshihara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Shinzaki S; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Amano T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Iijima H; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Inoue N; Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Uchino M; Department of Inflammatory Bowel Disease, Division of Surgery, Hyogo College of Medicine, Hyogo, Japan.
  • Esaki M; Division of Gastroenterology, Department of Internal Medicine, Saga University, Saga, Japan.
  • Kobayashi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
  • Saruta M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Sugimoto K; First Department of Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Nakamura S; Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan.
  • Hata K; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Hirai F; Department of Gastroenterology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Hiraoka S; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Fujii T; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Matsuura M; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Matsuoka K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center, Chiba, Japan.
  • Watanabe K; Division of Internal Medicine, Center for Inflammatory Bowel Disease, Hyogo College of Medicine, Hyogo, Japan.
  • Nakase H; Department of Gastroenterology and Hepatology, School of Medicine, Sapporo Medical University, Hokkaido, Japan.
  • Watanabe M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
J Gastroenterol Hepatol ; 36(7): 1744-1753, 2021 Jul.
Article en En | MEDLINE | ID: mdl-33450096
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab / Factores Inmunológicos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab / Factores Inmunológicos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón